# Protagonist Therapeutics, Inc: Form DEF 14A, filed Apr 29, 2025

- Company: [Protagonist Therapeutics, Inc](/companies/ptgx.md) (CIK 1377121)
- Form: DEF 14A
- Filed: 2025-04-29
- Accepted by EDGAR: Apr 29, 2025, 16:05 ET
- Period: 2025-06-20
- Accession: 0001104659-25-041206
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1377121/000110465925041206/tm252374-2_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1377121/000110465925041206/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1377121/000110465925041206/tm252374-2_def14a.htm

Filed Apr 29, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-041206. Last ingested by Listed: Nov 6, 2026, 12:26 ET. No prices; not investment advice.